|
NRBF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.012600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.224200E-02 |
| Normal-vs-Stage2 |
1.987570E-01 |
| Normal-vs-Stage3 |
4.376200E-02 |
| Normal-vs-Stage4 |
7.257800E-01 |
| Stage1-vs-Stage2 |
2.415700E-02 |
| Stage1-vs-Stage3 |
4.464900E-03 |
| Stage1-vs-Stage4 |
2.380400E-01 |
| Stage2-vs-Stage3 |
3.459800E-01 |
| Stage2-vs-Stage4 |
6.620600E-01 |
| Stage3-vs-Stage4 |
3.344000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.757800E-01 |
| Normal-vs-AfricanAmerican |
7.985800E-01 |
| Normal-vs-Asian |
6.460600E-01 |
| Caucasian-vs-AfricanAmerican |
2.621000E-01 |
| Caucasian-vs-Asian |
3.660600E-01 |
| AfricanAmerican-vs-Asian |
6.764800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.255030E-01 |
| Normal-vs-Female |
2.300000E-01 |
| Male-vs-Female |
1.750230E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.114000E-01 |
| Normal-vs-Extreme_Weight |
6.434200E-02 |
| Normal-vs-Obese |
5.758400E-01 |
| Normal-vs-Extreme_Obese |
7.211400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.768800E-01 |
| Normal_Weight-vs-Obese |
8.856200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.939600E-01 |
| Extreme_Weight-vs-Obese |
2.928000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.315200E-01 |
| Obese-vs-Extreme_Obese |
9.407800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.757700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.107200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.006800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.989700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.183900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.961900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.177700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.231350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.974600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.305600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.844350E-02 |
| Normal-VS-Type2 PRCC |
9.188000E-01 |
| Normal-VS-KIRP CIMP |
8.859700E-03 |
| Normal-VS-Unclassified PRCC |
6.271200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.505500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.600800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.222000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.573200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.476000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.817200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.547600E-01 |
| Normal-vs-N1 |
3.468400E-02 |
| Normal-vs-N2 |
7.239200E-01 |
| N0-vs-N1 |
3.258500E-02 |
| N0-vs-N2 |
6.709400E-01 |
| N1-vs-N2 |
5.708600E-01 |
|
|
